NTRA
Natera, Inc.$413.73-21.91 (-5.02%)Prev Close$436.00·MCap$58.36B·P/E—·Vol1.42M·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
137
$446.40M
◆
Net Activity
Net Seller
$446.40M
●
Active Insiders
12
last 12 mo
Over the past 12 months, insider activity at Natera, Inc. (NTRA) has been exclusively selling, with 0 insider purchases totaling $0.00 and 137 insider sales totaling $446.40M. The most recent insider transaction was by Brophy Michael Burkes (officer: CHIEF FINANCIAL OFFICER), who sold $1.31M worth of shares on Oct 30, 2026. Natera, Inc. operates in the Healthcare sector, within the Medical - Diagnostics & Research industry, with a market cap of $58.36B.
NTRA Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Oct 30, 2026 | Brophy Michael Burkes | officer: CHIEF FINANCIAL OFFICER | Sell | 3,084 | $425.90 | $1.31M | 49,345 |
| Oct 29, 2026 | Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | Sell | 2,172 | $416.88 | $905.5K | 105,904 |
| Oct 29, 2026 | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 478 | $413.96 | $197.9K | 217,873 |
| Oct 29, 2026 | RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | Sell | 1,852 | $416.63 | $771.6K | 169,189 |
| Oct 29, 2026 | Chapman Steven Leonard | director, officer: CEO AND PRESIDENT | Sell | 5,694 | $418.25 | $2.38M | 94,662 |
| Oct 29, 2026 | Brophy Michael Burkes | officer: CHIEF FINANCIAL OFFICER | Sell | 1,979 | $418.31 | $827.8K | 50,856 |
| Oct 29, 2026 | Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | Sell | 1,718 | $406.00 | $697.5K | 2,117,676 |
| Oct 29, 2026 | Fesko John | officer: PRESIDENT, CHIEF BUS. OFFICER | Sell | 1,679 | $416.88 | $699.9K | 196,476 |
| Oct 23, 2026 | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 3,150 | $410.55 | $1.29M | 221,114 |
| Oct 20, 2026 | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 1,050 | $402.11 | $422.2K | 8,858 |
| Oct 16, 2026 | Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | Sell | 48,500 | $402.92 | $19.54M | 2,169,108 |
| Oct 2, 2026 | Chapman Steven Leonard | director, officer: CEO AND PRESIDENT | Sell | 1,273 | $413.31 | $526.1K | 96,926 |
| Oct 2, 2026 | Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | Sell | 3,000 | $414.22 | $1.24M | 109,714 |
| Sep 25, 2026 | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 18,064 | $388.01 | $7.01M | 17,642-51% |
| Sep 17, 2026 | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 8,950 | $351.57 | $3.15M | 224,464 |
| Sep 16, 2026 | Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | Sell | 99,300 | $341.03 | $33.86M | 2,223,857 |
| Sep 11, 2026 | Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | Sell | 50,000 | $327.97 | $16.40M | 2,274,594 |
| Sep 3, 2026 | Chapman Steven Leonard | director, officer: CEO AND PRESIDENT | Sell | 1,698 | $320.99 | $545.0K | 98,199 |
| Sep 3, 2026 | Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | Sell | 18,160 | $325.88 | $5.92M | 128,019 |
| Aug 28, 2026 | Fesko John | officer: PRESIDENT, CHIEF BUS. OFFICER | Sell | 6,517 | $321.53 | $2.10M | 197,257 |
| Aug 14, 2026 | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 6,000 | $325.32 | $1.95M | 230,464 |
| Aug 7, 2026 | Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | Sell | 2,000 | $320.90 | $641.8K | 2,000-50% |
| Aug 7, 2026 | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 8,650 | $316.00 | $2.73M | 244,714 |
| Aug 5, 2026 | Fesko John | officer: PRESIDENT, CHIEF BUS. OFFICER | Sell | 295 | $267.99 | $79.1K | 183,774 |
| Aug 5, 2026 | Chapman Steven Leonard | director, officer: CEO AND PRESIDENT | Sell | 3,076 | $266.40 | $819.4K | 101,791 |
| Aug 5, 2026 | Brophy Michael Burkes | officer: CHIEF FINANCIAL OFFICER | Sell | 795 | $271.74 | $216.0K | 52,115 |
| Aug 5, 2026 | RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | Sell | 334 | $267.99 | $89.5K | 170,073 |
| Aug 5, 2026 | Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | Sell | 731 | $267.99 | $195.9K | 2,275,394 |
| Aug 5, 2026 | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 109 | $267.99 | $29.2K | 245,614 |
| Aug 5, 2026 | Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | Sell | 3,410 | $265.58 | $905.6K | 132,019 |
| Jul 29, 2026 | Fesko John | officer: PRESIDENT, CHIEF BUS. OFFICER | Sell | 1,713 | $257.00 | $440.2K | 185,000 |
| Jul 29, 2026 | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 479 | $257.93 | $123.5K | 245,914 |
| Jul 29, 2026 | Brophy Michael Burkes | officer: CHIEF FINANCIAL OFFICER | Sell | 5,064 | $253.28 | $1.28M | 56,714 |
| Jul 29, 2026 | Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | Sell | 1,718 | $260.49 | $447.5K | 2,276,125 |
| Jul 29, 2026 | Chapman Steven Leonard | director, officer: CEO AND PRESIDENT | Sell | 5,770 | $256.51 | $1.48M | 106,553 |
| Jul 29, 2026 | Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | Sell | 2,214 | $257.00 | $569.0K | 133,633 |
| Jul 29, 2026 | RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | Sell | 1,887 | $257.08 | $485.1K | 171,410 |
| Jul 17, 2026 | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 1,500 | $273.88 | $410.8K | 18,392 |
| Jul 17, 2026 | Chapman Rowan E | director | Sell | 135 | $274.82 | $37.1K | 4,663 |
| Jul 15, 2026 | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 2,150 | $266.12 | $572.2K | 248,052 |
| Jul 8, 2026 | Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | Sell | 1,000 | $280.00 | $280.0K | 4,000 |
| Jul 6, 2026 | RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | Sell | 16,800 | $272.29 | $4.57M | 187,526 |
| Jul 6, 2026 | Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | Sell | 3,000 | $272.90 | $818.7K | 137,543 |
| Jun 26, 2026 | RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | Sell | 33,600 | $251.65 | $8.46M | 206,490 |
| Jun 26, 2026 | ROSENMAN HERM | director | Sell | 16,530 | $250.00 | $4.13M | 4,250-80% |
| Jun 22, 2026 | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 1,500 | $219.87 | $329.8K | 19,276 |
| Jun 17, 2026 | Chapman Rowan E | director | Sell | 2,964 | $216.78 | $642.5K | 3,124-49% |
| Jun 17, 2026 | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 3,150 | $211.14 | $665.1K | 250,752 |
| Jun 16, 2026 | Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | Sell | 100,000 | $214.47 | $21.45M | 2,375,307 |
| Jun 9, 2026 | Marcus Gail Boxer | director | Sell | 11,000 | $217.21 | $2.39M | 14,167-44% |
Showing 1–50 of 599
1 / 12
...
NTRA Insider Buying Activity
The following table shows recent insider purchases of Natera, Inc. (NTRA) stock reported via SEC Form 4 filings.
No insider buying activity found for NTRA in the last 12 months.
NTRA Insider Selling Activity
The following table shows recent insider sales of Natera, Inc. (NTRA) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Oct 30, 2026 | Brophy Michael Burkes | officer: CHIEF FINANCIAL OFFICER | Sell | 3,084 | $425.90 | $1.31M | 49,345 |
| Oct 29, 2026 | Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | Sell | 2,172 | $416.88 | $905.5K | 105,904 |
| Oct 29, 2026 | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 478 | $413.96 | $197.9K | 217,873 |
| Oct 29, 2026 | RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | Sell | 1,852 | $416.63 | $771.6K | 169,189 |
| Oct 29, 2026 | Chapman Steven Leonard | director, officer: CEO AND PRESIDENT | Sell | 5,694 | $418.25 | $2.38M | 94,662 |
| Oct 29, 2026 | Brophy Michael Burkes | officer: CHIEF FINANCIAL OFFICER | Sell | 1,979 | $418.31 | $827.8K | 50,856 |
| Oct 29, 2026 | Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | Sell | 1,718 | $406.00 | $697.5K | 2,117,676 |
| Oct 29, 2026 | Fesko John | officer: PRESIDENT, CHIEF BUS. OFFICER | Sell | 1,679 | $416.88 | $699.9K | 196,476 |
| Oct 23, 2026 | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 3,150 | $410.55 | $1.29M | 221,114 |
| Oct 20, 2026 | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 1,050 | $402.11 | $422.2K | 8,858 |
| Oct 16, 2026 | Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | Sell | 48,500 | $402.92 | $19.54M | 2,169,108 |
| Oct 2, 2026 | Chapman Steven Leonard | director, officer: CEO AND PRESIDENT | Sell | 1,273 | $413.31 | $526.1K | 96,926 |
| Oct 2, 2026 | Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | Sell | 3,000 | $414.22 | $1.24M | 109,714 |
| Sep 25, 2026 | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 18,064 | $388.01 | $7.01M | 17,642-51% |
| Sep 17, 2026 | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 8,950 | $351.57 | $3.15M | 224,464 |
| Sep 16, 2026 | Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | Sell | 99,300 | $341.03 | $33.86M | 2,223,857 |
| Sep 11, 2026 | Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | Sell | 50,000 | $327.97 | $16.40M | 2,274,594 |
| Sep 3, 2026 | Chapman Steven Leonard | director, officer: CEO AND PRESIDENT | Sell | 1,698 | $320.99 | $545.0K | 98,199 |
| Sep 3, 2026 | Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | Sell | 18,160 | $325.88 | $5.92M | 128,019 |
| Aug 28, 2026 | Fesko John | officer: PRESIDENT, CHIEF BUS. OFFICER | Sell | 6,517 | $321.53 | $2.10M | 197,257 |
| Aug 14, 2026 | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 6,000 | $325.32 | $1.95M | 230,464 |
| Aug 7, 2026 | Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | Sell | 2,000 | $320.90 | $641.8K | 2,000-50% |
| Aug 7, 2026 | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 8,650 | $316.00 | $2.73M | 244,714 |
| Aug 5, 2026 | Fesko John | officer: PRESIDENT, CHIEF BUS. OFFICER | Sell | 295 | $267.99 | $79.1K | 183,774 |
| Aug 5, 2026 | Chapman Steven Leonard | director, officer: CEO AND PRESIDENT | Sell | 3,076 | $266.40 | $819.4K | 101,791 |
| Aug 5, 2026 | Brophy Michael Burkes | officer: CHIEF FINANCIAL OFFICER | Sell | 795 | $271.74 | $216.0K | 52,115 |
| Aug 5, 2026 | RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | Sell | 334 | $267.99 | $89.5K | 170,073 |
| Aug 5, 2026 | Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | Sell | 731 | $267.99 | $195.9K | 2,275,394 |
| Aug 5, 2026 | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 109 | $267.99 | $29.2K | 245,614 |
| Aug 5, 2026 | Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | Sell | 3,410 | $265.58 | $905.6K | 132,019 |
| Jul 29, 2026 | Fesko John | officer: PRESIDENT, CHIEF BUS. OFFICER | Sell | 1,713 | $257.00 | $440.2K | 185,000 |
| Jul 29, 2026 | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 479 | $257.93 | $123.5K | 245,914 |
| Jul 29, 2026 | Brophy Michael Burkes | officer: CHIEF FINANCIAL OFFICER | Sell | 5,064 | $253.28 | $1.28M | 56,714 |
| Jul 29, 2026 | Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | Sell | 1,718 | $260.49 | $447.5K | 2,276,125 |
| Jul 29, 2026 | Chapman Steven Leonard | director, officer: CEO AND PRESIDENT | Sell | 5,770 | $256.51 | $1.48M | 106,553 |
| Jul 29, 2026 | Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | Sell | 2,214 | $257.00 | $569.0K | 133,633 |
| Jul 29, 2026 | RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | Sell | 1,887 | $257.08 | $485.1K | 171,410 |
| Jul 17, 2026 | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 1,500 | $273.88 | $410.8K | 18,392 |
| Jul 17, 2026 | Chapman Rowan E | director | Sell | 135 | $274.82 | $37.1K | 4,663 |
| Jul 15, 2026 | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 2,150 | $266.12 | $572.2K | 248,052 |
| Jul 8, 2026 | Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | Sell | 1,000 | $280.00 | $280.0K | 4,000 |
| Jul 6, 2026 | RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | Sell | 16,800 | $272.29 | $4.57M | 187,526 |
| Jul 6, 2026 | Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | Sell | 3,000 | $272.90 | $818.7K | 137,543 |
| Jun 26, 2026 | RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | Sell | 33,600 | $251.65 | $8.46M | 206,490 |
| Jun 26, 2026 | ROSENMAN HERM | director | Sell | 16,530 | $250.00 | $4.13M | 4,250-80% |
| Jun 22, 2026 | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 1,500 | $219.87 | $329.8K | 19,276 |
| Jun 17, 2026 | Chapman Rowan E | director | Sell | 2,964 | $216.78 | $642.5K | 3,124-49% |
| Jun 17, 2026 | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 3,150 | $211.14 | $665.1K | 250,752 |
| Jun 16, 2026 | Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | Sell | 100,000 | $214.47 | $21.45M | 2,375,307 |
| Jun 9, 2026 | Marcus Gail Boxer | director | Sell | 11,000 | $217.21 | $2.39M | 14,167-44% |
NTRA Insiders
Similar Stocks to NTRA
TMO
Thermo Fisher Scientific Inc.
$695.46-1.97%
$253.24B
DHR
Danaher Corporation
$232.46-1.91%
$163.77B
A
Agilent Technologies, Inc.
$175.31-3.22%
$49.61B
WAT
Waters Corporation
$461.66-3.84%
$46.82B
IQV
IQVIA Holdings Inc.
$266.23-3.21%
$44.98B
IDXX
IDEXX Laboratories, Inc.
$553.83-3.85%
$44.92B
ILMN
Illumina, Inc.
$236.85-18.37%
$43.61B
MTD
Mettler-Toledo International Inc.
$1676.90-2.43%
$34.03B